Intel Corporation filings document the formal record for a Nasdaq-listed semiconductor company with common stock registered under the Exchange Act. Recent disclosures cover quarterly results, segment revenue for Intel Products and Intel Foundry, senior note offerings, shelf registration statements, resale securities tied to a U.S. Department of Commerce agreement, and material events affecting Intel’s capital structure.
Intel’s SEC filings also address governance, director elections, board leadership, executive compensation, stockholder proposals, risk oversight, cybersecurity oversight, executive officer changes, and ownership of manufacturing-related assets such as the Fab 34 joint venture in Ireland. Proxy statements and 8-K reports provide the principal public record for these governance, financing, operating, and corporate-status matters.
Intel and related parties amended their April 14, 2025 transaction agreement to sell a majority interest in the Altera business. Amendment No. 1, entered August 11, 2025, makes technical changes to the purchase price calculation that the company does not expect to materially affect net cash proceeds. The amendment also shifts the earliest allowable closing to no earlier than September 12, 2025 and extends the outside closing date to September 13, 2025, providing additional time to satisfy closing conditions. The filing reiterates standard forward-looking disclosures and lists potential risks that could prevent or delay completion.
Intel Corp filed a Form 13F reporting institutional holdings with a Form 13F Information Table total value of $255,517,497. The report lists 3 table entries and names two other included managers: Intel Capital Corporation and Middlefield Ventures, Inc.
The filing is signed by Patrick Bombach, Assistant Corporate Secretary, and the report indicates this is a 13F holdings report.